Syndax Pharmaceuticals Inc - SNDX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$2.488B
QoQ value delta ($000)
+$345.2M (+16.11%)
Implied price effect (QoQ)
+10.3%
Shares
Total shares
107,385,384
QoQ shares delta
+5,373,246 (+5.27%)
Total shares held by funds (by quarter)

Market chart (SNDX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 246 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock, Inc. 192,823 8,254,426 0.0%
Kynam Capital Management, LP 188,070 8,050,959 11.6%
VANGUARD GROUP INC 130,899 6,230,334 0.0%
GOLDMAN SACHS GROUP INC 116,724 4,996,787 0.01%
STATE STREET CORP 103,486 4,430,076 0.0%
BANK OF AMERICA CORP /DE/ 99,276 4,249,836 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 89,295 3,822,579 0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. 88,298 3,779,900 1.04%
Eversept Partners, LP 67,408 2,885,622 3.55%
KINGDON CAPITAL MANAGEMENT, L.L.C. 58,400 2,500,000 6.41%
Hood River Capital Management LLC 54,996 2,354,285 0.55%
GEODE CAPITAL MANAGEMENT, LLC 50,399 2,157,058 0.0%
FRANKLIN RESOURCES INC 50,225 2,150,079 0.01%
Point72 Asset Management, L.P. 46,382 1,985,547 0.06%
Elmind Capital, LP 43,332 1,855,000 12.3%
VANGUARD PORTFOLIO MANAGEMENT LLC 40,579 1,737,141 0.0%
BNP Paribas Asset Management Holding S.A. 40,472 1,732,541 0.05%
Soleus Capital Management, L.P. 40,340 1,726,908 1.63%
D. E. Shaw & Co., Inc. 37,420 1,601,896 0.02%
TWO SIGMA INVESTMENTS, LP 36,899 1,579,596 0.03%
Nuveen, LLC 34,914 1,494,645 0.01%
MPM BioImpact LLC 31,319 1,340,733 2.42%
Aisling Capital Management LP 30,760 1,316,806 6.46%
Woodline Partners LP 29,217 1,250,760 0.11%
STEMPOINT CAPITAL LP 28,489 1,365,743 5.54%